Skip to main content

Table 2 The descriptive data and comparative statistics of cephalometric measurements in the two groups

From: Comparison of the effects of rapid maxillary expansion versus Twin Block appliance on mandibular growth in skeletal Class II patients

Cephalometric Measurements

RME Group

TB Group

P1

P2

Pc

T1

T2

Change

P1-2

T1

T2

Change

P1-2

Regular items

 SNA (°)

80.73 ± 2.75

79.91 ± 2.35

− 0.82 ± 1.37

0.042*

80.82 ± 2.73

79.73 ± 3.82

− 1.09 ± 2.16

0.072

0.929

0.885

0.698

 SNB (°)

74.29 ± 2.34

75.90 ± 2.35

1.61 ± 1.19

0.000

74.15 ± 2.44

75.61 ± 3.52

1.47 ± 1.73

0.005

0.877

0.800

0.792

 ANB (°)

6.44 ± 0.96

4.01 ± 1.24

− 2.44 ± 1.19

0.000

6.67 ± 0.81

4.12 ± 1.70

− 2.55 ± 1.56

0.000

0.489

0.840

0.822

 Z angle (°)

55.60 ± 5.80

67.86 ± 5.84

12.26 ± 6.17

0.000

54.51 ± 5.20

66.36 ± 6.48

11.85 ± 5.83

0.000

0.599

0.520

0.855

 FMA (°)

28.05 ± 3.70

28.40 ± 3.44

0.35 ± 1.57

0.419

28.67 ± 4.10

31.31 ± 3.95

2.65 ± 1.05

0.000

0.675

0.044*

0.000

Mandible to cranio base

 SNPog (°)

74.70 ± 2.45

76.61 ± 2.40

1.91 ± 1.34

0.000

73.83 ± 2.66

76.37 ± 3.42

2.55 ± 1.43

0.000

0.366

0.829

0.232

 NSGn (°)

74.49 ± 2.48

73.81 ± 2.62

− 0.67 ± 1.26

0.067

72.87 ± 2.74

72.53 ± 3.40

− 0.34 ± 1.54

0.405

0.109

0.269

0.542

 NSAr (°)

121.96 ± 3.83

120.03 ± 4.29

− 1.94 ± 2.07

0.004

124.19 ± 3.52

123.93 ± 3.06

− 0.27 ± 1.75

0.566

0.114

0.009

0.026*

 Pog-N|FH (mm)

10.92 ± 4.53

9.59 ± 7.10

− 1.34 ± 4.56

0.293

14.12 ± 4.25

12.35 ± 6.78

− 1.77 ± 6.00

0.273

0.060

0.292

0.830

Skeletal mandibular items

 PFH (mm)

42.54 ± 2.65

47.28 ± 5.09

4.74 ± 3.62

0.000

42.22 ± 3.07

48.05 ± 4.50

5.83 ± 3.47

0.000

0.770

0.670

0.418

 LAFH (mm)

57.24 ± 3.74

62.38 ± 3.76

5.14 ± 2.88

0.000

55.99 ± 3.18

66.19 ± 4.52

10.19 ± 3.13

0.000

0.343

0.021*

0.000

 PFH/LAFH (%)

74.54 ± 5.74

75.84 ± 7.39

1.30 ± 5.02

0.352

75.55 ± 5.80

72.70 ± 6.07

− 2.84 ± 3.93

0.014*

0.643

0.221

0.020*

 SE (mm)

16.75 ± 2.28

17.85 ± 2.68

1.10 ± 1.33

0.009

17.85 ± 2.54

20.07 ± 2.60

2.23 ± 1.56

0.000

0.233

0.032*

0.046*

 SL (mm)

33.32 ± 5.05

37.11 ± 5.26

3.79 ± 3.48

0.001

33.63 ± 4.36

38.35 ± 6.45

4.71 ± 3.10

0.000

0.860

0.577

0.454

 Ar-Gn (mm)

94.72 ± 6.00

104.54 ± 8.02

9.81 ± 5.47

0.000

91.08 ± 4.04

102.59 ± 5.74

11.51 ± 4.85

0.000

0.064

0.457

0.383

 Co-Gn (mm)

100.04 ± 6.36

112.01 ± 8.39

11.97 ± 5.58

0.000

96.66 ± 5.99

109.41 ± 7.48

12.75 ± 6.21

0.000

0.152

0.385

0.725

 Go-Gn (mm)

68.44 ± 4.39

74.31 ± 5.63

5.88 ± 3.42

0.000

66.37 ± 3.60

73.73 ± 4.98

7.37 ± 4.13

0.000

0.175

0.770

0.302

 Co-Go (mm)

53.94 ± 3.58

60.23 ± 5.48

6.29 ± 3.86

0.000

51.82 ± 3.29

59.89 ± 6.57

8.07 ± 4.59

0.000

0.108

0.883

0.268

 ArGoMe (°)

122.45 ± 3.78

123.86 ± 4.97

1.41 ± 2.81

0.083

119.55 ± 5.67

121.43 ± 6.01

1.88 ± 2.24

0.006

0.120

0.248

0.625

  1. Data are presented as mean ± SD; T1: before treatment; T2: completion of phase II treatment; P1-2: the difference of cephalometric measurements before and after treatment in each group; P1: the difference of cephalometric measurements between the RME group and the TB group at T1; P2: the difference of cephalometric measurements between the RME group and the TB group at T2; Pc: the difference of changes of cephalometric measurements from T1 to T2 between the RME group and the TB group; P < 0.05, P < 0.01 and P < 0.001 = significant; *P < 0.05; P < 0.01; P < 0.001